Skip to Main Content

Knowledge Center

Underwriting

Liquid Biopsies: Fact, Fiction, or Both?

Is science fiction becoming science fact? Liquid biopsies are a new class of blood- (or other bodily fluid-based) tests that can reveal direct evidence of cancer and are far less invasive than traditional biopsies. RGA's Dr. Daniel Zimmerman explores linkages between advances in genetics and this new technology. He also investigates limitations, potential mortality and morbidity impacts, and insurance implications. 

If you would like to discuss this webcast further please e-mail us at: CMSTeam@rgare.com

 
https://player.vimeo.com/video/351643063
  • antiselection life insurance
  • Daniel Zimmerman
  • DTC genetic testing life insurance
  • epigenetics life insurance
  • genetic information insurance
  • genetic risk score life insurance
  • genomic life insurance
  • immunotherapy insurance risk
  • liquid biopsy underwriting risk
  • microbiome insurance risk
  • polygenetic score insurance
  • precision medicine life insurance
  • radiosurgery underwriting
  • robotic surgery underwriting
  • stem cell therapy underwriting risk
  • Zimmerman